{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:04Z","timestamp":1791919084706,"version":"4.3.4"},"reference-count":69,"publisher":"American Society of Hematology","issue":"20","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>JAK2V617F is one of the most common mutations in clonal hematopoiesis of indeterminate potential (CHIP) and a major driver of myeloproliferative neoplasms (MPNs). To determine the impact of a low-frequency JAK2V617F clone on both the hematopoietic system and the bone marrow (BM) stroma, we developed a traceable murine MPN model, in which whole BM transplantation (BMT) was performed using CD45.2 5.0 \u00d7 106 JAK2V617F donor cells transplanted into unconditioned CD45.1 recipient mice. BMT recipients developed a polycythemia vera\u2013like phenotype (elevated hematocrit and leukocytosis) with a 2.7% average donor cell chimerism in peripheral blood. Eight months after BMT, RNA sequencing (RNA-seq) analysis of BM cells sorted according to CD45.1\/CD45.2 expression showed significant upregulation of early erythroblast- and myeloid cell\u2013specific transcripts, and downregulation of lymphoid transcripts in donor-derived cells compared to controls. Surprisingly, recipient-derived cells also showed upregulation of myeloid- and erythroblast-related transcripts, indicating a skewing of the non\u2013JAK2V617F-carrying recipient hematopoietic system toward an MPN-like phenotype. In addition, RNA-seq analysis of the BM stroma from JAK2V617F BMT recipients indicated significant loss of osteomesenchymal transcripts. Consistently, micro\u2013computed tomography imaging indicated loss of trabecular bone. In sum, our results indicate that low-frequency MPN-driving cells in unconditioned recipients not only impact hematopoiesis-supporting stroma but also profoundly influence unmutated cells, uniquely altering their transcriptomic and phenotypic profiles. These observations are challenging our current understanding of the etiology and therapeutic approaches to MPNs and other CHIP-associated diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2024027125","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:53:45Z","timestamp":1753822425000},"page":"2428-2442","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["HiJAKing the hematopoietic system: a low-frequency JAK2V617F clone drives myeloproliferative neoplasm pathology"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-1209","authenticated-orcid":false,"given":"Dennis M.","family":"Bonal","sequence":"first","affiliation":[{"name":"1Brown University Pathobiology Graduate Program, Brown University, Providence, RI"},{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3719-2603","authenticated-orcid":false,"given":"Alissa","family":"Oakes","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"},{"name":"3Molecular Pharmacology and Physiology Graduate Program, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-0259","authenticated-orcid":false,"given":"Anna","family":"Chorzalska","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6777-2289","authenticated-orcid":false,"given":"Makayla","family":"Pardo","sequence":"additional","affiliation":[{"name":"1Brown University Pathobiology Graduate Program, Brown University, Providence, RI"},{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3179-4619","authenticated-orcid":false,"given":"Max","family":"Petersen","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"},{"name":"4Center on the Biology of Aging, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1616-9025","authenticated-orcid":false,"given":"Michael Y.","family":"Clarke","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3343-5294","authenticated-orcid":false,"given":"Seo-Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-6658","authenticated-orcid":false,"given":"Adam J.","family":"Olszewski","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"},{"name":"5Legorreta Cancer Center, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7346-9219","authenticated-orcid":false,"given":"Diana O.","family":"Treaba","sequence":"additional","affiliation":[{"name":"1Brown University Pathobiology Graduate Program, Brown University, Providence, RI"},{"name":"5Legorreta Cancer Center, Brown University, Providence, RI"},{"name":"6Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-6863","authenticated-orcid":false,"given":"John L.","family":"Reagan","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"},{"name":"5Legorreta Cancer Center, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-6562","authenticated-orcid":false,"given":"Mark","family":"Dooner","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0649-0015","authenticated-orcid":false,"given":"John","family":"Morgan","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-4829","authenticated-orcid":false,"given":"Paul","family":"Bertone","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"},{"name":"5Legorreta Cancer Center, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1622-2663","authenticated-orcid":false,"given":"Ting C.","family":"Zhao","sequence":"additional","affiliation":[{"name":"7Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2127-6239","authenticated-orcid":false,"given":"Wentian","family":"Yang","sequence":"additional","affiliation":[{"name":"5Legorreta Cancer Center, Brown University, Providence, RI"},{"name":"8Department of Orthopedics, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4223-4775","authenticated-orcid":false,"given":"Corey E.","family":"Ventetuolo","sequence":"additional","affiliation":[{"name":"9Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Warren Alpert Medical School of Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0199-9333","authenticated-orcid":false,"given":"Gabriela S.","family":"Hobbs","sequence":"additional","affiliation":[{"name":"10Department of Hematology-Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-8756","authenticated-orcid":false,"given":"Joslyn","family":"Mills","sequence":"additional","affiliation":[{"name":"11Department of Biological Sciences, Bartlett College of Science and Mathematics, Bridgewater State University, Bridgewater, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3987-0647","authenticated-orcid":false,"given":"Patrycja M.","family":"Dubielecka","sequence":"additional","affiliation":[{"name":"1Brown University Pathobiology Graduate Program, Brown University, Providence, RI"},{"name":"2Department of Medicine, Division of Hematology-Oncology, Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI"},{"name":"3Molecular Pharmacology and Physiology Graduate Program, Brown University, Providence, RI"},{"name":"4Center on the Biology of Aging, Brown University, Providence, RI"},{"name":"5Legorreta Cancer Center, Brown University, Providence, RI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"9464","key":"2025111311214718500_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"issue":"7037","key":"2025111311214718500_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"issue":"17","key":"2025111311214718500_bib3","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"2025111311214718500_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"2","key":"2025111311214718500_bib5","doi-asserted-by":"crossref","first-page":"a006251","DOI":"10.1101\/mcs.a006251","article-title":"Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation","volume":"9","author":"Goldman","year":"2023","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"26","key":"2025111311214718500_bib6","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"2025111311214718500_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","volume":"134","author":"Cordua","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2025111311214718500_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br J Haematol"},{"issue":"26","key":"2025111311214718500_bib9","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2025111311214718500_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Rep"},{"issue":"1","key":"2025111311214718500_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood-2006-03-009472","article-title":"JAK2V617F: prevalence in a large Chinese hospital population","volume":"109","author":"Xu","year":"2006","journal-title":"Blood"},{"issue":"9","key":"2025111311214718500_bib12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3324\/haematol.2014.107631","article-title":"JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate","volume":"99","author":"Nielsen","year":"2014","journal-title":"Haematologica"},{"issue":"16","key":"2025111311214718500_bib13","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"issue":"22","key":"2025111311214718500_bib14","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1158\/0008-5472.CAN-22-0985","article-title":"Clonal hematopoiesis of indeterminate potential in patients with solid tumor malignancies","volume":"82","author":"Marshall","year":"2022","journal-title":"Cancer Res"},{"issue":"9","key":"2025111311214718500_bib15","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.6004\/jnccn.2022.0046","article-title":"Myeloproliferative neoplasms, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Gerds","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"7913","key":"2025111311214718500_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","article-title":"The longitudinal dynamics and natural history of clonal haematopoiesis","volume":"606","author":"Fabre","year":"2022","journal-title":"Nature"},{"issue":"14","key":"2025111311214718500_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1182\/bloodadvances.2017007047","article-title":"JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics","volume":"1","author":"McKerrell","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"2025111311214718500_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.stem.2021.02.001","article-title":"Reconstructing the lineage histories and differentiation trajectories of individual cancer cells in myeloproliferative neoplasms","volume":"28","author":"Van Egeren","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"7895","key":"2025111311214718500_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","article-title":"Life histories of myeloproliferative neoplasms inferred from phylogenies","volume":"602","author":"Williams","year":"2022","journal-title":"Nature"},{"issue":"7","key":"2025111311214718500_bib20","doi-asserted-by":"crossref","first-page":"a031328","DOI":"10.1101\/cshperspect.a031328","article-title":"The bone marrow microenvironment in health and myeloid malignancy","volume":"8","author":"Gal\u00e1n-D\u00edez","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"2025111311214718500_bib21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","article-title":"A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia","volume":"177","author":"Baryawno","year":"2019","journal-title":"Cell"},{"issue":"478","key":"2025111311214718500_bib22","doi-asserted-by":"crossref","first-page":"622519","DOI":"10.3389\/fcell.2021.622519","article-title":"Connecting the dots: resolving the bone marrow niche heterogeneity","volume":"9","author":"Dolgalev","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025111311214718500_bib23","unstructured":"Thapa\n              B\n            , FazalS, ParsiM, RogersHJ. Myeloproliferative Neoplasms In: StatPearls Publishing LLC [Internet]. Accessed 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531464\/."},{"issue":"3","key":"2025111311214718500_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11899-019-00508-w","article-title":"Key role of inflammation in myeloproliferative neoplasms: instigator of disease initiation, progression and symptoms","volume":"14","author":"Mendez","year":"2019","journal-title":"Curr Hematologic Malignancy Rep"},{"key":"2025111311214718500_bib25","doi-asserted-by":"crossref","first-page":"1196817","DOI":"10.3389\/fonc.2023.1196817","article-title":"Mutations, inflammation and phenotype of myeloproliferative neoplasms","volume":"13","author":"Hermouet","year":"2023","journal-title":"Front Oncol"},{"issue":"17","key":"2025111311214718500_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM197610212951702","article-title":"Polycythemia vera: stem-cell and probable clonal origin of the disease","volume":"295","author":"Adamson","year":"1976","journal-title":"N Engl J Med"},{"issue":"4","key":"2025111311214718500_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.2021014668","article-title":"Single-cell methods in myeloproliferative neoplasms: old questions, new technologies","volume":"141","author":"O'Sullivan","year":"2023","journal-title":"Blood"},{"issue":"23","key":"2025111311214718500_bib28","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2017-06-782037","article-title":"Myeloproliferative neoplasms: from origins to outcomes","volume":"130","author":"Nangalia","year":"2017","journal-title":"Blood"},{"key":"2025111311214718500_bib29","doi-asserted-by":"crossref","first-page":"869242","DOI":"10.1155\/2015\/869242","article-title":"Cytokine regulation of microenvironmental cells in myeloproliferative neoplasms","volume":"2015","author":"Hoermann","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"8","key":"2025111311214718500_bib30","doi-asserted-by":"crossref","first-page":"e0182470","DOI":"10.1371\/journal.pone.0182470","article-title":"Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis","volume":"12","author":"Ramos","year":"2017","journal-title":"PLoS One"},{"key":"2025111311214718500_bib31","doi-asserted-by":"crossref","first-page":"6720594","DOI":"10.1155\/2017\/6720594","article-title":"Mesenchymal stem cells in myeloid malignancies: a focus on immune escaping and therapeutic implications","volume":"2017","author":"Fracchiolla","year":"2017","journal-title":"Stem Cells Int"},{"issue":"1","key":"2025111311214718500_bib32","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1097\/HS9.0000000000000327","article-title":"Modifiable lifestyle and medical risk factors associated with myeloproliferative neoplasms","volume":"4","author":"Duncombe","year":"2020","journal-title":"Hemasphere"},{"issue":"7","key":"2025111311214718500_bib33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/oby.21863","article-title":"Obesity and related risk of myeloproliferative neoplasms among Israeli adolescents","volume":"25","author":"Leiba","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"2025111311214718500_bib34","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3324\/haematol.2009.020412","article-title":"Autoimmunity and the risk of myeloproliferative neoplasms","volume":"95","author":"Sigurdur","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"2025111311214718500_bib35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"issue":"6","key":"2025111311214718500_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"issue":"5229","key":"2025111311214718500_bib37","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"K\u00fchn","year":"1995","journal-title":"Science"},{"issue":"6","key":"2025111311214718500_bib38","doi-asserted-by":"crossref","first-page":"e135204","DOI":"10.1172\/jci.insight.135204","article-title":"Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction","volume":"5","author":"Wang","year":"2024","journal-title":"JCI Insight"},{"issue":"19","key":"2025111311214718500_bib39","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2018-05-848408","article-title":"Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis","volume":"132","author":"Chorzalska","year":"2018","journal-title":"Blood"},{"issue":"21","key":"2025111311214718500_bib40","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1073\/pnas.82.21.7360","article-title":"Cloning of Ly-5 cDNA","volume":"82","author":"Shen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7755","key":"2025111311214718500_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","article-title":"The bone marrow microenvironment at single-cell resolution","volume":"569","author":"Tikhonova","year":"2019","journal-title":"Nature"},{"key":"2025111311214718500_bib42","unstructured":"R Core Team\n          . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Accessed 2024. https:\/\/www.R-project.org\/."},{"issue":"1","key":"2025111311214718500_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stemcr.2016.06.002","article-title":"Potential pitfalls of the Mx1-Cre system: implications for experimental modeling of normal and malignant hematopoiesis","volume":"7","author":"Velasco-Hernandez","year":"2016","journal-title":"Stem Cell Rep"},{"issue":"6","key":"2025111311214718500_bib44","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"issue":"11","key":"2025111311214718500_bib45","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"issue":"20","key":"2025111311214718500_bib46","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2013-06-510222","article-title":"JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2025111311214718500_bib47","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1371\/journal.pone.0000018","article-title":"Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F","volume":"1","author":"Zaleskas","year":"2006","journal-title":"PLoS One"},{"key":"2025111311214718500_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exphem.2018.09.004","article-title":"The Human Cell Atlas bone marrow single-cell interactive web portal","volume":"68","author":"Hay","year":"2018","journal-title":"Exp Hematol"},{"issue":"7","key":"2025111311214718500_bib49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2025111311214718500_bib50","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"Cell"},{"issue":"9","key":"2025111311214718500_bib51","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood-2009-12-259747","article-title":"JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"issue":"7745","key":"2025111311214718500_bib52","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","article-title":"The single-cell transcriptional landscape of mammalian organogenesis","volume":"566","author":"Cao","year":"2019","journal-title":"Nature"},{"issue":"2","key":"2025111311214718500_bib53","first-page":"275","article-title":"False discovery rates: a new deal","volume":"18","author":"Stephens","year":"2016","journal-title":"Biostatistics"},{"issue":"9","key":"2025111311214718500_bib54","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1038\/s41375-021-01159-8","article-title":"Early detection of myeloproliferative neoplasms in a Danish general population study","volume":"35","author":"Cordua","year":"2021","journal-title":"Leukemia"},{"issue":"8","key":"2025111311214718500_bib55","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3390\/cancers12082038","article-title":"Impact of host, lifestyle and environmental factors in the pathogenesis of MPN","volume":"12","author":"Ramanathan","year":"2020","journal-title":"Cancers"},{"issue":"9","key":"2025111311214718500_bib56","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/cells10092316","article-title":"The power of extracellular vesicles in myeloproliferative neoplasms: \u201ccrafting\u201d a microenvironment that matters","volume":"10","author":"Catani","year":"2021","journal-title":"Cells"},{"issue":"4","key":"2025111311214718500_bib57","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3390\/cancers15041348","article-title":"Deepening our understanding of the factors affecting landscape of myeloproliferative neoplasms: what do we know about them?","volume":"15","author":"Morales","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10","key":"2025111311214718500_bib58","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/jbmr.4678","article-title":"Osteoblast lineage support of hematopoiesis in health and disease","volume":"37","author":"Kim","year":"2022","journal-title":"Journal of Bone and Mineral Research"},{"issue":"4","key":"2025111311214718500_bib59","doi-asserted-by":"crossref","first-page":"101564","DOI":"10.1016\/j.beem.2021.101564","article-title":"Bone marrow adiposity and the hematopoietic niche: a historical perspective of reciprocity, heterogeneity, and lineage commitment","volume":"35","author":"Tratwal","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2025111311214718500_bib60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.2023023788","article-title":"Bone marrow niches for hematopoietic stem cells: life span dynamics and adaptation to acute stress","volume":"144","author":"Hofmann","year":"2024","journal-title":"Blood"},{"issue":"1","key":"2025111311214718500_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.04.021","article-title":"Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-\u03baB-dependent manner","volume":"15","author":"Wang","year":"2014","journal-title":"Cell Stem Cell"},{"key":"2025111311214718500_bib62","doi-asserted-by":"crossref","first-page":"618308","DOI":"10.3389\/fgeed.2020.618308","article-title":"Mesenchymal stromal cells as a cellular target in myeloid malignancy: chances and challenges in the genome editing of stromal alterations","volume":"2","author":"Banjanin","year":"2020","journal-title":"Front Genome"},{"issue":"12","key":"2025111311214718500_bib63","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1182\/blood-2008-03-148999","article-title":"Defective Notch activation in microenvironment leads to myeloproliferative disease","volume":"112","author":"Kim","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2025111311214718500_bib64","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jcb.24755","article-title":"Osteoblasts protect AML cells from SDF-1-induced apoptosis","volume":"115","author":"Kremer","year":"2014","journal-title":"J Cell Biochem"},{"issue":"21","key":"2025111311214718500_bib65","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1182\/bloodadvances.2021005938","article-title":"Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8\/A9high AML cell subset","volume":"6","author":"B\u00f6ttcher","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"2025111311214718500_bib66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"13","key":"2025111311214718500_bib67","doi-asserted-by":"crossref","first-page":"e90036","DOI":"10.1172\/jci.insight.90036","article-title":"AML-induced osteogenic differentiation in mesenchymal stromal cells supports leukemia growth","volume":"2","author":"Battula","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"2025111311214718500_bib68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10428194.2020.1817437","article-title":"Highly increased risk of fracture in patients with myeloproliferative neoplasm","volume":"62","author":"Johansson","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2025111311214718500_bib69","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41591-022-01793-4","article-title":"In utero origin of myelofibrosis presenting in adult monozygotic twins","volume":"28","author":"Sousos","year":"2022","journal-title":"Nat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2024027125\/2420064\/blood_bld-2024-027125-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/doi\/10.1182\/blood.2024027125\/2420064\/blood_bld-2024-027125-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T16:22:03Z","timestamp":1763050923000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/20\/2428\/546399\/HiJAKing-the-hematopoietic-system-a-low-frequency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":69,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,11,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2024027125","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,13]]},"published":{"date-parts":[[2025,11,13]]}}}